<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39417078</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in microbiology</Title><ISOAbbreviation>Front Microbiol</ISOAbbreviation></Journal><ArticleTitle>Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice.</ArticleTitle><Pagination><StartPage>1466980</StartPage><MedlinePgn>1466980</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1466980</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2024.1466980</ELocationID><Abstract><AbstractText>Owing to their continuous evolution, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) display disparate pathogenicity in mouse models. Omicron and its sublineages have been dominant worldwide. Compared to pre-Omicron VOCs, early Omicron subvariants reportedly cause attenuated disease in human ACE-2-expressing mice (K18-hACE-2). In late 2022, the frequency of Omicron subvariant XBB.1.5 rapidly increased and it progressively replaced other circulating strains. The emergence of new strains requires current SARS-CoV-2 clinical animal model re-evaluation. In this study, we aim to characterize XBB.1.5 pathogenesis in K18-hACE-2. Herein, we demonstrated that XBB.1.5 infection is associated with significant weight loss, severe lung pathology, and substantial mortality. Intranasal XBB.1.5 infection resulted in 100% mortality in K18-hACE2 mice. High virus titers were detected in the lungs on days 3 and 5 after infection. Moreover, XBB.1.5 productively infected the cells within the nasal turbinate, olfactory bulb, intestines, and kidneys. In addition, in a subset of infected mice, we detected high virus titers in the brain. Consistently, we detected high viral antigen expression in the lungs. Furthermore, we observed severe lung injury hallmarks (e.g., immune cell infiltration, perivascular cuffing, and alveolar consolidation). Using immunofluorescence labeling and cytometric analysis, we revealed that XBB.1.5 infection leads to CD45<sup>+</sup> cell influx into the lung parenchyma. We further demonstrated that most immune infiltrates are CD11b<sup>+</sup> CD11c<sup>+</sup> dendritic cells. Additionally, we detected significant induction of proinflammatory cytokines and chemokines in infected lungs. Taken together, our data show that Omicron subvariant XBB.1.5 is highly pathogenic in K18-hACE2 mice.</AbstractText><CopyrightInformation>Copyright © 2024 Elsharkawy, Stone, Guglani, Patterson, Ge, Dim, Miano and Kumar.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elsharkawy</LastName><ForeName>Amany</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, GA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Diagnostics and Therapeutics, Georgia State University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Shannon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guglani</LastName><ForeName>Anchala</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patterson</LastName><ForeName>Lila D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Chunyu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dim</LastName><ForeName>Chinonye</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miano</LastName><ForeName>Joseph M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Mukesh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, GA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Diagnostics and Therapeutics, Georgia State University, Atlanta, GA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Microbiol</MedlineTA><NlmUniqueID>101548977</NlmUniqueID><ISSNLinking>1664-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE-2 expressing mice</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 variants of concern</Keyword><Keyword MajorTopicYN="N">XBB.1.5</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>10</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>17</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39417078</ArticleId><ArticleId IdType="pmc">PMC11480052</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2024.1466980</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Auroni T. T., Arora K., Natekar J. P., Pathak H., Elsharkawy A., Kumar M. (2023). The critical role of interleukin-6 in protection against neurotropic flavivirus infection. Front. Cell. Infect. Microbiol. 13:1275823. doi: 10.3389/fcimb.2023.1275823</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1275823</ArticleId><ArticleId IdType="pmc">PMC10694511</ArticleId><ArticleId IdType="pubmed">38053527</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu M., Zurla C., Auroni T. T., Vanover D., Chaves L. C. S., Sadhwani H., et al. . (2024). mRNA-encoded Cas13 can be used to treat dengue infections in mice. Nat. Microbiol. 9, 2160–2172. doi: 10.1038/s41564-024-01726-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-024-01726-6</ArticleId><ArticleId IdType="pubmed">38839984</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Zhao B., Qu Y., Chen Y., Xiong J., Feng Y., et al. . (2020). Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients with coronavirus disease 2019. Clin. Infect. Dis. 71, 1937–1942. doi: 10.1093/cid/ciaa449</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa449</ArticleId><ArticleId IdType="pmc">PMC7184354</ArticleId><ArticleId IdType="pubmed">32301997</ArticleId></ArticleIdList></Reference><Reference><Citation>Davitt E., Davitt C., Mazer M. B., Areti S. S., Hotchkiss R. S., Remy K. E. (2022). COVID-19 disease and immune dysregulation. Best Pract. Res. Clin. Haematol. 35:101401. doi: 10.1016/j.beha.2022.101401, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beha.2022.101401</ArticleId><ArticleId IdType="pmc">PMC9568269</ArticleId><ArticleId IdType="pubmed">36494149</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W., Mead H., Tian L., Park J. G., Garcia J. I., Jaramillo S., et al. . (2022). The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus. J. Virol. 96:e0096421. doi: 10.1128/JVI.00964-21, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00964-21</ArticleId><ArticleId IdType="pmc">PMC8754221</ArticleId><ArticleId IdType="pubmed">34668775</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y., Li X., Zhang L., Wan S., Zhang L., Zhou F. (2022). SARS-CoV-2 omicron variant: recent progress and future perspectives. Signal Transduct. Target. Ther. 7:141. doi: 10.1038/s41392-022-00997-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00997-x</ArticleId><ArticleId IdType="pmc">PMC9047469</ArticleId><ArticleId IdType="pubmed">35484110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabarre P., Dumas G., Dupont T., Darmon M., Azoulay E., Zafrani L. (2020). Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 46, 1339–1348. doi: 10.1007/s00134-020-06153-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06153-9</ArticleId><ArticleId IdType="pmc">PMC7290076</ArticleId><ArticleId IdType="pubmed">32533197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanam A. R., Bryant W. B., Miano J. M. (2022). Of mice and human-specific long noncoding RNAs. Mamm. Genome 33, 281–292. doi: 10.1007/s00335-022-09943-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00335-022-09943-2</ArticleId><ArticleId IdType="pmc">PMC8806012</ArticleId><ArticleId IdType="pubmed">35106622</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A., Weiskopf D., Ramirez S. I., Mateus J., Dan J. M., Moderbacher C. R., et al. . (2020). Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489–1501.e15. doi: 10.1016/j.cell.2020.05.015, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7237901</ArticleId><ArticleId IdType="pubmed">32473127</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfmann P. J., Lida S., Iwatsuki-Horimoto K., Maemura T., Kiso M., Scheaffer S. M., et al. . (2022). SARS-CoV-2 omicron virus causes attenuated disease in mice and hamsters. Nature 603, 687–692. doi: 10.1038/s41586-022-04441-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04441-6</ArticleId><ArticleId IdType="pmc">PMC8942849</ArticleId><ArticleId IdType="pubmed">35062015</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y., Yang B., Yang J., Shi X., Yang X., Zhang D., et al. . (2022). ZBP1: a powerful innate immune sensor and double-edged sword in host immunity. Int. J. Mol. Sci. 23:10224. doi: 10.3390/ijms231810224, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231810224</ArticleId><ArticleId IdType="pmc">PMC9499459</ArticleId><ArticleId IdType="pubmed">36142136</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui K. P. Y., Ho J. C. W., Cheung M. C., Ng K. C., Ching R. H. H., Lai K. L., et al. . (2022). SARS-CoV-2 omicron variant replication in human respiratory tract ex vivo. Nature 603, 715–720. doi: 10.1038/s41586-022-04479-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04479-6</ArticleId><ArticleId IdType="pubmed">35104836</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhun H., Park H. Y., Hisham Y., Song C. S., Kim S. (2021). SARS-COV-2 delta (B.1.617.2) variant: a unique T478K mutation in receptor binding motif (RBM) of spike gene. Immune Netw. 21:e32. doi: 10.4110/in.2021.21.e32, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2021.21.e32</ArticleId><ArticleId IdType="pmc">PMC8568914</ArticleId><ArticleId IdType="pubmed">34796036</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R., Lee S., Mall R., Pandian N., Wang Y., Sharma B. R., et al. . (2022). ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci. Immunol. 7:eabo6294. doi: 10.1126/sciimmunol.abo6294, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abo6294</ArticleId><ArticleId IdType="pmc">PMC9161373</ArticleId><ArticleId IdType="pubmed">35587515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Thambiraja T. S., Karuppanan K., Subramaniam G. (2022). Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein. J. Med. Virol. 94, 1641–1649. doi: 10.1002/jmv.27526</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27526</ArticleId><ArticleId IdType="pubmed">34914115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari P., Rothan H. A., Natekar J. P., Stone S., Pathak H., Strate P. G., et al. . (2021). Neuroinvasion and encephalitis following intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice. Viruses 13:132. doi: 10.3390/v13010132, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010132</ArticleId><ArticleId IdType="pmc">PMC7832889</ArticleId><ArticleId IdType="pubmed">33477869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurhade C., Zou J., Xia H., Liu M., Chang H. C., Ren P., et al. . (2023). Low neutralization of SARS-CoV-2 omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nat. Med. 29, 344–347. doi: 10.1038/s41591-022-02162-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02162-x</ArticleId><ArticleId IdType="pubmed">36473500</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Zhang Y., Guan Z., Ye M., Li H., You M., et al. . (2023). SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses. Cell Res. 33, 201–214. doi: 10.1038/s41422-022-00775-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-022-00775-y</ArticleId><ArticleId IdType="pmc">PMC9844202</ArticleId><ArticleId IdType="pubmed">36650286</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínez-Flores D., Zepeda-Cervantes J., Cruz-Reséndiz A., Aguirre-Sampieri S., Sampieri A., Vaca L. (2021). SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants. Front. Immunol. 12:701501. doi: 10.3389/fimmu.2021.701501, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.701501</ArticleId><ArticleId IdType="pmc">PMC8311925</ArticleId><ArticleId IdType="pubmed">34322129</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray P. B., Jr., Pewe L., Wohlford-Lenane C., Hickey M., Manzel L., Shi L., et al. . (2007). Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 81, 813–821. doi: 10.1128/JVI.02012-06, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02012-06</ArticleId><ArticleId IdType="pmc">PMC1797474</ArticleId><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference><Reference><Citation>Natekar J. P., Pathak H., Stone S., Kumari P., Sharma S., Auroni T. T., et al. . (2022). Differential pathogenesis of SARS-CoV-2 variants of concern in human ACE2-expressing mice. Viruses 14:1139. doi: 10.3390/v14061139, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14061139</ArticleId><ArticleId IdType="pmc">PMC9231291</ArticleId><ArticleId IdType="pubmed">35746611</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyberg T., Ferguson N. M., Nash S. G., Webster H. H., Flaxman S., Andrews N., et al. . (2022). Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet 399, 1303–1312. doi: 10.1016/S0140-6736(22)00462-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00462-7</ArticleId><ArticleId IdType="pmc">PMC8926413</ArticleId><ArticleId IdType="pubmed">35305296</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S.-J., Kumari P., Auroni T. T., Stone S., Pathak H., Elsharkawy A., et al. . (2024). Upregulation of Neuroinflammation-associated genes in the brain of SARS-CoV-2-infected mice. Pathogens 13:528. doi: 10.3390/pathogens13070528, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens13070528</ArticleId><ArticleId IdType="pmc">PMC11280415</ArticleId><ArticleId IdType="pubmed">39057755</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel N., Trost J. F., Guebre-Xabier M., Zhou H., Norton J., Jiang D., et al. . (2023). XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants. Sci. Rep. 13:19176. doi: 10.1038/s41598-023-46025-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-46025-y</ArticleId><ArticleId IdType="pmc">PMC10628164</ArticleId><ArticleId IdType="pubmed">37932354</ArticleId></ArticleIdList></Reference><Reference><Citation>Roe K., Kumar M., Lum S., Orillo B., Nerurkar V. R., Verma S. (2012). West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J. Gen. Virol. 93, 1193–1203. doi: 10.1099/vir.0.040899-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.040899-0</ArticleId><ArticleId IdType="pmc">PMC3755517</ArticleId><ArticleId IdType="pubmed">22398316</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeld R., Noy-Porat T., Mechaly A., Makdasi E., Levy Y., Alcalay R., et al. . (2021). Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody. Nat. Commun. 12:944. doi: 10.1038/s41467-021-21239-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21239-8</ArticleId><ArticleId IdType="pmc">PMC7878817</ArticleId><ArticleId IdType="pubmed">33574228</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan H. A., Kumari P., Stone S., Natekar J. P., Arora K., Auroni T. T., et al. . (2022). SARS-CoV-2 infects primary neurons from human ACE2 expressing mice and upregulates genes involved in the inflammatory and necroptotic pathways. Pathogens 11:257. doi: 10.3390/pathogens11020257, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020257</ArticleId><ArticleId IdType="pmc">PMC8876293</ArticleId><ArticleId IdType="pubmed">35215199</ArticleId></ArticleIdList></Reference><Reference><Citation>Stankov M. V., Hoffmann M., Gutierrez Jauregui R., Cossmann A., Ramos G. M., Graalmann T., et al. . (2024). Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination. Lancet Infect. Dis. 24, e1–e3. doi: 10.1016/S1473-3099(23)00690-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00690-4</ArticleId><ArticleId IdType="pubmed">37995739</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart R., Yan K., Ellis S. A., Bishop C. R., Dumenil T., Tang B., et al. . (2023). SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids. Front. Microbiol. 14:1320856. doi: 10.3389/fmicb.2023.1320856, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1320856</ArticleId><ArticleId IdType="pmc">PMC10706942</ArticleId><ArticleId IdType="pubmed">38075874</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone S., Rothan H. A., Natekar J. P., Kumari P., Sharma S., Pathak H., et al. . (2021). SARS-CoV-2 variants of concern infect the respiratory tract and induce inflammatory response in wild-type laboratory mice. Viruses 14:27. doi: 10.3390/v14010027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14010027</ArticleId><ArticleId IdType="pmc">PMC8777867</ArticleId><ArticleId IdType="pubmed">35062231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Zhu A., Li H., Zheng K., Zhuang Z., Chen Z., et al. . (2020). Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg. Microbes Infect. 9, 991–993. doi: 10.1080/22221751.2020.1760144, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1760144</ArticleId><ArticleId IdType="pmc">PMC7301718</ArticleId><ArticleId IdType="pubmed">32342724</ArticleId></ArticleIdList></Reference><Reference><Citation>Uraki R., Ito M., Furusawa Y., Yamayoshi S., Iwatsuki-Horimoto K., Adachi E., et al. . (2023). Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB BQ.1.1 and XBB. Lancet Infect. Dis. 23, 30–32. doi: 10.1016/S1473-3099(22)00816-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00816-7</ArticleId><ArticleId IdType="pmc">PMC9729000</ArticleId><ArticleId IdType="pubmed">36495917</ArticleId></ArticleIdList></Reference><Reference><Citation>Uriu K., Ito J., Zahradnik J., Fujita S., Kosugi Y., Schreiber G., et al. . (2023). Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant XBB.1.5 variant. Lancet Infect. Dis. 23, 280–281. doi: 10.1016/S1473-3099(23)00051-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00051-8</ArticleId><ArticleId IdType="pmc">PMC9889095</ArticleId><ArticleId IdType="pubmed">36736338</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oosten L., Yan K., Rawle D. J., Le T. T., Altenburg J. J., Fougeroux C., et al. . (2022). An S1-nanoparticle vaccine protects against SARS-CoV-2 challenge in K18-hACE2 mice. J. Virol. 96:e0084422. doi: 10.1128/jvi.00844-22, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00844-22</ArticleId><ArticleId IdType="pmc">PMC9327679</ArticleId><ArticleId IdType="pubmed">35766489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Guo Y., Bowen A., Mellis I. A., Valdez R., Gherasim C., et al. . (2024). XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1. Cell Host Microbe 32, 315–321.e3. doi: 10.1016/j.chom.2024.01.014, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2024.01.014</ArticleId><ArticleId IdType="pmc">PMC10948033</ArticleId><ArticleId IdType="pubmed">38377995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Hou H., Luo Y., Tang G., Wu S., Huang M., et al. . (2020). The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight 5:e137799. doi: 10.1172/jci.insight.137799, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.137799</ArticleId><ArticleId IdType="pmc">PMC7259533</ArticleId><ArticleId IdType="pubmed">32324595</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., et al. . (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323, 1061–1069. doi: 10.1001/jama.2020.1585, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Iketani S., Li Z., Liu L., Guo Y., Huang Y., et al. . (2023). Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell 186, 279–286.e8. doi: 10.1016/j.cell.2022.12.018, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.12.018</ArticleId><ArticleId IdType="pmc">PMC9747694</ArticleId><ArticleId IdType="pubmed">36580913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward I. L., Bermingham C., Ayoubkhani D., Gethings O. J., Pouwels K. B., Yates T., et al. . (2022). Risk of Covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study. BMJ 378:e070695. doi: 10.1136/bmj-2022-070695, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-070695</ArticleId><ArticleId IdType="pmc">PMC9344192</ArticleId><ArticleId IdType="pubmed">35918098</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E. S., Bailey A. L., Kafai N. M., Nair S., McCune B. T., Yu J., et al. . (2020). SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327–1335. doi: 10.1038/s41590-020-0778-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0778-2</ArticleId><ArticleId IdType="pmc">PMC7578095</ArticleId><ArticleId IdType="pubmed">32839612</ArticleId></ArticleIdList></Reference><Reference><Citation>Won T., Wood M. K., Hughes D. M., Talor M. V., Ma Z., Schneider J., et al. . (2022). Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs. EBioMedicine 75:103812. doi: 10.1016/j.ebiom.2022.103812</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103812</ArticleId><ArticleId IdType="pmc">PMC8756077</ArticleId><ArticleId IdType="pubmed">35033854</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323, 1239–1242. doi: 10.1001/jama.2020.2648, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Sun J., Xu Y., Li F., Huang X., Li H., et al. . (2020). Infectious SARS-CoV-2 in feces of patient with severe COVID-19. Emerg. Infect. Dis. 26, 1920–1922. doi: 10.3201/eid2608.200681, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2608.200681</ArticleId><ArticleId IdType="pmc">PMC7392466</ArticleId><ArticleId IdType="pubmed">32421494</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Shen C., Li J., Yuan J., Wei J., Huang F., et al. . (2020). Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J. Allergy Clin. Immunol. 146, 119–127.e4. doi: 10.1016/j.jaci.2020.04.027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7189843</ArticleId><ArticleId IdType="pubmed">32360286</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue C., Song W., Wang L., Jian F., Chen X., Gao F., et al. . (2023). ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5 of XBB.1.5. Lancet Infect. Dis. 23, 278–280. doi: 10.1016/S1473-3099(23)00010-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00010-5</ArticleId><ArticleId IdType="pmc">PMC9897732</ArticleId><ArticleId IdType="pubmed">36746173</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Zhao J., Deng L., Ishimwe N., Pauli J., Wu W., et al. . (2023). INKILN is a novel long noncoding RNA promoting vascular smooth muscle inflammation via scaffolding MKL1 and USP10. Circulation 148, 47–67. doi: 10.1161/CIRCULATIONAHA.123.063760, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.123.063760</ArticleId><ArticleId IdType="pmc">PMC10330325</ArticleId><ArticleId IdType="pubmed">37199168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Ren L., Zhang L., Zhong J., Xiao Y., Jia Z., et al. . (2020). Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe 27, 883–890.e2. doi: 10.1016/j.chom.2020.04.017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7196896</ArticleId><ArticleId IdType="pubmed">32407669</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Yang X. L., Wang X. G., Hu B., Zhang L., Zhang W., et al. . (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273. doi: 10.1038/s41586-020-2012-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>